Bone Morphogenetic Protein 2

The FDA has granted breakthrough therapy designation to sotatercept for treatment of pulmonary arterial hypertension, according to a press release from Acceleron Pharma.

Some factors related to the patient or surgery, including inadequate blood flow and fracture stability, can result in fracture nonunion. However, literature shows most of these traumatic fractures promptly heal after surgical treatment. For those that do not, sources told Orthopedics Today the use of orthobiologics may provide a needed boost in healing.